Generics attack validity of Neurim insomnia drug patent

Intellectual Property 2019-04-05 8:28 pm | Sydney
Two generic pharmaceutical companies, Generic Partners and Apotex, have filed cross-claims alleging that Neurim Pharmaceuticals’ patent for its insomnia drug Circadin is invalid and should be revoked.
For information on rights and reprints, contact subscriptions@lawyerly.com.au